nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anaphylaxis after vaccination of children: Review of literature and recommendations for vaccination in child and school health services in Belgium
|
Vanlander, Anouk |
|
2014 |
32 |
26 |
p. 3147-3154 8 p. |
artikel |
2 |
A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung
|
Neuhaus, Vanessa |
|
2014 |
32 |
26 |
p. 3216-3222 7 p. |
artikel |
3 |
Antibody avidity measurements in recipients of Cervarix ® vaccine following a two-dose schedule or a three-dose schedule
|
Boxus, Mathieu |
|
2014 |
32 |
26 |
p. 3232-3236 5 p. |
artikel |
4 |
Anti-diphtheria immunity in Nigerian mothers and their newborns
|
Cummings, Henry |
|
2014 |
32 |
26 |
p. 3211-3215 5 p. |
artikel |
5 |
Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct
|
Céspedes, Nora |
|
2014 |
32 |
26 |
p. 3179-3186 8 p. |
artikel |
6 |
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines
|
Donahue, Renee N. |
|
2014 |
32 |
26 |
p. 3223-3231 9 p. |
artikel |
7 |
Assurance of neuroattenuation of a live vaccine against West Nile virus: A comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine
|
Maximova, Olga A. |
|
2014 |
32 |
26 |
p. 3187-3197 11 p. |
artikel |
8 |
Breast milk and Group B streptococcal infection: Vector of transmission or vehicle for protection?
|
Le Doare, Kirsty |
|
2014 |
32 |
26 |
p. 3128-3132 5 p. |
artikel |
9 |
Chemically induced Salmonella enteritidis ghosts as a novel vaccine candidate against virulent challenge in a rat model
|
Vinod, Nagarajan |
|
2014 |
32 |
26 |
p. 3249-3255 7 p. |
artikel |
10 |
Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models
|
Boukhebza, Houda |
|
2014 |
32 |
26 |
p. 3256-3263 8 p. |
artikel |
11 |
Consultation on dengue vaccines: Progress in understanding protection, 26–28 June 2013, Rockville, Maryland
|
Cassetti, M. Cristina |
|
2014 |
32 |
26 |
p. 3115-3121 7 p. |
artikel |
12 |
Disease-related adverse events following non-live vaccines: Investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase
|
Roberto, Giuseppe |
|
2014 |
32 |
26 |
p. 3328-3335 8 p. |
artikel |
13 |
Does oral polio vaccine at birth affect the size of the thymus? Observations within a randomized trial
|
Eriksen, Helle Brander |
|
2014 |
32 |
26 |
p. 3293-3299 7 p. |
artikel |
14 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
26 |
p. CO2- 1 p. |
artikel |
15 |
Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice
|
El Bissati, Kamal |
|
2014 |
32 |
26 |
p. 3243-3248 6 p. |
artikel |
16 |
Footrot vaccines and vaccination
|
Dhungyel, Om |
|
2014 |
32 |
26 |
p. 3139-3146 8 p. |
artikel |
17 |
Formal training in vaccine safety to address parental concerns not routinely conducted in U.S. pediatric residency programs
|
Williams, S. Elizabeth |
|
2014 |
32 |
26 |
p. 3175-3178 4 p. |
artikel |
18 |
Intranasally administered Endocine™ formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets
|
Maltais, Anna-Karin |
|
2014 |
32 |
26 |
p. 3307-3315 9 p. |
artikel |
19 |
In vivo immunogenicity of Tax(11–19) epitope in HLA-A2/DTR transgenic mice: Implication for dendritic cell-based anti-HTLV-1 vaccine
|
Sagar, Divya |
|
2014 |
32 |
26 |
p. 3274-3284 11 p. |
artikel |
20 |
Morbillivirus vaccines: Recent successes and future hopes
|
Buczkowski, Hubert |
|
2014 |
32 |
26 |
p. 3155-3161 7 p. |
artikel |
21 |
Mucosal immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine herpesvirus-1 gD and bovine IL-6
|
Kumar, Pankaj |
|
2014 |
32 |
26 |
p. 3300-3306 7 p. |
artikel |
22 |
National and state-specific estimates of place of influenza vaccination among adult populations – United States, 2011–12 influenza season
|
Lu, Peng-jun |
|
2014 |
32 |
26 |
p. 3198-3204 7 p. |
artikel |
23 |
Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells
|
Mishra, Sasmita |
|
2014 |
32 |
26 |
p. 3285-3292 8 p. |
artikel |
24 |
Planning for human papillomavirus (HPV) vaccination in sub-Saharan Africa: A modeling-based approach
|
Tracy, J. Kathleen |
|
2014 |
32 |
26 |
p. 3316-3322 7 p. |
artikel |
25 |
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
|
Coleman, Christopher M. |
|
2014 |
32 |
26 |
p. 3169-3174 6 p. |
artikel |
26 |
Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studies
|
Naleway, Allison L. |
|
2014 |
32 |
26 |
p. 3122-3127 6 p. |
artikel |
27 |
Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model
|
Jones, Bart G. |
|
2014 |
32 |
26 |
p. 3264-3273 10 p. |
artikel |
28 |
Therapeutic vaccines for tuberculosis—A systematic review
|
Gröschel, Matthias I. |
|
2014 |
32 |
26 |
p. 3162-3168 7 p. |
artikel |
29 |
Toward more specific and transparent research and development costs: The case of seasonal influenza vaccines
|
Chit, Ayman |
|
2014 |
32 |
26 |
p. 3336-3340 5 p. |
artikel |
30 |
Two-dose strategies for human papillomavirus vaccination: How well do they need to protect?
|
Jit, Mark |
|
2014 |
32 |
26 |
p. 3237-3242 6 p. |
artikel |
31 |
Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model
|
Verhoeven, David |
|
2014 |
32 |
26 |
p. 3205-3210 6 p. |
artikel |
32 |
Vaccine perception among acceptors and non-acceptors in Sokoto State, Nigeria
|
Murele, Bola |
|
2014 |
32 |
26 |
p. 3323-3327 5 p. |
artikel |
33 |
Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
|
Gessner, Bradford D. |
|
2014 |
32 |
26 |
p. 3133-3138 6 p. |
artikel |